Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Liver synthetic and metabolic function can only be optimised by the growth of cells within a supportive liver matrix. This can be achieved by the utilisation of decellularised human liver tissue. Here we demonstrate complete decellularization of whole human liver and lobes to form an extracellular matrix scaffold with a preserved architecture. Decellularized human liver cubic scaffolds were repopulated for up to 21 days using human cell lines hepatic stellate cells (LX2), hepatocellular carcinoma (Sk-Hep-1) and hepatoblastoma (HepG2), with excellent viability, motility and proliferation and remodelling of the extracellular matrix. Biocompatibility was demonstrated by either omental or subcutaneous xenotransplantation of liver scaffold cubes (5 × 5 × 5 mm) into immune competent mice resulting in absent foreign body responses. We demonstrate decellularization of human liver and repopulation with derived human liver cells. This is a key advance in bioartificial liver development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Peracetic acid (PAA) at a concentration of 0.1 % is the most commonly used acid for decellularization and sterilization of liver; however, it has adverse effects on GAGs, growth factors, and the mechanical characteristics of ECM [12,15,[103], [104], [105], [106], [107]].”
From Liver tissue engineering using decellularized scaffolds: Current progress, challenges, and opportunities (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HepG2 cells efficiently repopulate decellularized rat, porcine, and human livers while retaining their function and proliferative capacity [14,15,204].”
From Liver tissue engineering using decellularized scaffolds: Current progress, challenges, and opportunities (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a decellularized extracellular matrix (dECM) scaffold in which all cells are removed from the organ but the organ-specific architectures and biochemical niches remain has been a promising substrate for liver tissue engineering4,5.”
From Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation (2023) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring the global burden of disease
Murray, C. J. L., & Lopez, A. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1201534 · Cited by 1,818
Uygun, B. E., Soto-Gutierrez, A., Yagi, H., Izamis, M.-L., Guzzardi, M. A., Shulman, C., Milwid, J., Kobayashi, N., Tilles, A., Berthiaume, F., et al. (2010) · Nature Medicine · doi:10.1038/nm.2170 · Cited by 1,370
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
Fox, I. J., Chowdhury, J. R., Kaufman, S. S., Goertzen, T. C., Chowdhury, N. R., Warkentin, P. I., Dorko, K., Sauter, B. V., & Strom, S. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382004 · Cited by 1,023
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
Xu, L., Hui, A. Y., Albanis, E., Arthur, M. J., O’Byrne, S. M., Blaner, W. S., Mukherjee, P., Friedman, S. L., & Eng, F. J. (2005) · Gut · doi:10.1136/gut.2004.042127 · Cited by 1,014
The use of whole organ decellularization for the generation of a vascularized liver organoid
Baptista, P. M., Siddiqui, M. M., Lozier, G., Rodriguez, S. R., Atala, A., & Soker, S. (2011) · Hepatology · doi:10.1002/hep.24067 · Cited by 681
The utility of marginal donors in liver transplantation
Busuttil, R. W., & Tanaka, K. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50105 · Cited by 662
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a
Muraca, M., Gerunda, G., Neri, D., Vilei, M.-T., Granato, A., Feltracco, P., Meroni, M., Giron, G., & Burlina, A. B. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07529-3 · Cited by 383
Decellularized tissue-engineered blood vessel as an arterial conduit
Quint, C., Kondo, Y., Manson, R. J., Lawson, J. H., Dardik, A., & Niklason, L. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019506108 · Cited by 368
A Whole-Organ Regenerative Medicine Approach for Liver Replacement
Soto-Gutierrez, A., Zhang, L., Medberry, C., Fukumitsu, K., Faulk, D., Jiang, H., Reing, J., Gramignoli, R., Komori, J., Ross, M., et al. (2011) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0698 · Cited by 311
Cited by
Items 101–200 of 424
3D Bioprinting: Recent Trends and Challenges
Chameettachal, S., Yeleswarapu, S., Sasikumar, S., Shukla, P., Hibare, P., Bera, A. K., Bojedla, S. S. R., & Pati, F. (2019) · Journal of the Indian Institute of Science · doi:10.1007/s41745-019-00113-z · Cited by 57
Mattei, G., Magliaro, C., Pirone, A., & Ahluwalia, A. (2017) · Artificial Organs · doi:10.1111/aor.12925 · Cited by 50
“Porcine liver decellularized ECM, whose mechano-structural and physicochemical features have been shown to be donorindependent (21,23,24), may represent an attractive candidate as a template for deriving scaffold specifications, because human primary hepatocytes exhibit good metabolic competency when cultured on porci…”
BackgroundInfluentialGurevich, I., Burton, S. A., Munn, C., Ohshima, M., Goedland, M. E., Czysz, K., & Rajesh, D. (2020) · Biology Open · doi:10.1242/bio.055087 · Cited by 46
“…can be induced in monolayer cultures of primary human hepatocytes and iPSC derived hepatocytes (Parafati et al., 2018), such cultures rapidly decline in their performance owing to spontaneous loss inxenobioticmetabolismcapacityandhormone responsiveness (Berger et al., 2015; Mazza et al., 2015).”
Ravichandran, A., Murekatete, B., Moedder, D., Meinert, C., & Bray, L. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-94990-z · Cited by 46
Zhang, X., Xiao, S., Liu, B., Miao, Y., & Hu, Z. (2019) · Regenerative Medicine · doi:10.2217/rme-2018-0112 · Cited by 47
A novel surgical technique for a rat subcutaneous implantation of a tissue engineered scaffold
Khorramirouz, R., Go, J. L., Noble, C., Jana, S., Maxson, E. L., Lerman, A., & Young, M. D. (2018) · Acta Histochemica · doi:10.1016/j.acthis.2018.02.010 · Cited by 48
Kim, Y., Kim, Y. W., Lee, S. B., Kang, K., Yoon, S., Choi, D., Park, S.-H., & Jeong, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120899 · Cited by 46
Agarwal, T., Narayan, R., Maji, S., Ghosh, S. K., & Maiti, T. K. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2594 · Cited by 46
Kovačević, B., Jones, M., Ionescu, C. M., Walker, D., Wagle, S. R., Chester, J., Foster, T., Brown, D. J., Mikov, M., Mooranian, A., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121459 · Cited by 46
Self-citationDuarte, M. M., Silva, I. V., Eisenhut, A. R., Bionda, N., Duarte, A. R. C., & Oliveira, A. L. (2022) · Materials Horizons · doi:10.1039/d1mh01720a · Cited by 45
Ergun, C., Parmaksiz, M., Vurat, M. T., Elçin, A. E., & Elçin, Y. M. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.086 · Cited by 45
Meran, L., Tullie, L., Eaton, S. D., Coppi, P. D., & Li, V. S. W. (2022) · Nature Protocols · doi:10.1038/s41596-022-00751-1 · Cited by 50
Yajima, Y., Lee, C. N., Yamada, M., Utoh, R., & Seki, M. (2018) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2018.01.022 · Cited by 45
Hussein, K. H., Park, K.-M., Yu, L., Song, S.-H., Woo, H.-M., & Kwak, H.-H. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.12.029 · Cited by 44
From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix
Willemse, J., Lieshout, R., van der Laan, L. J. W., & Verstegen, M. M. A. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.03.003 · Cited by 50
Kargar-Abarghouei, E., Vojdani, Z., Hassanpour, A., Alaee, S., & Talaei‐Khozani, T. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1062-3 · Cited by 44
“The effective removal of DNA and cell debris from the decellularized tissue led to better migration of the host cells to the scaffold and also reduced the inappropriate immune response [28, 29]; however, we also found a mild immune cell infiltration including CD68-positive macrophages and lymphocytes, as well.”
Recellularization of Native Tissue Derived Acellular Scaffolds with Mesenchymal Stem Cells
Ahmed, E., Saleh, T., & Xu, M. (2021) · Cells · doi:10.3390/cells10071787 · Cited by 46
Tetsuka, K., Ohbuchi, M., & Tabata, K. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.05.010 · Cited by 44
Advances in Hepatic Tissue Bioengineering with Decellularized Liver Bioscaffold
Rossi, E. A., Quintanilha, L. F., Nonaka, C. K. V., & Souza, B. S. D. F. (2019) · Stem Cells International · doi:10.1155/2019/2693189 · Cited by 42
“The experiments were conducted mainly in the rat liver [8–19], as well as in mouse [20], pig [21–24], sheep [19], ferret [11], minipig [25], and human [26, 27] liver tissues.”
BackgroundMethodResultInfluentialAllu, I., Sahi, A. K., Koppadi, M., Gundu, S., & Sionkowska, A. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14100518 · Cited by 44
“, the 3D architecture and ultrastructure and laminin were also conserved [104,107,109,116,123].”
BackgroundMethodInfluentialRobotic approach to hepatobiliary surgery
Gonzalez-Ciccarelli, L. F., Quadri, P., Daskalaki, D., Milone, L., Gangemi, A., & Giulianotti, P. C. (2016) · Der Chirurg · doi:10.1007/s00104-016-0223-0 · Cited by 41
Kehtari, M., Beiki, B., Zeynali, B., Hosseini, F. S., Soleimanifar, F., Kaabi, M., Soleimani, M., Enderami, S. E., Kabiri, M., & Mahboudi, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27965 · Cited by 44
Miyauchi, Y., Yasuchika, K., Fukumitsu, K., Ishii, T., Ogiso, S., Minami, T., Kojima, H., Yamaoka, R., Katayama, H., Kawai, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09391-y · Cited by 40
Ko, E., Alberti, K., Lee, J. S., Yang, K., Jin, Y., Shin, J., Yang, H. S., Xu, Q., & Cho, S.-W. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b05358 · Cited by 39
Acun, A., Oganesyan, R., Uygun, K., Yeh, H., Yarmush, M. L., & Uygun, B. E. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120689 · Cited by 39
“Up to date, the reports of whole human liver decellularization show decellularization of 1 to 3 livers[8], [10], [30] and the effect of donor age dependent differences in decellularization efficiency is not explored.”
BackgroundLiver Cancer: Current and Future Trends Using Biomaterials
Chew, S. A., Moscato, S., George, S., Azimi, B., & Danti, S. (2019) · Cancers · doi:10.3390/cancers11122026 · Cited by 45
“were able to completely decellularize human liver with maintenance of the original parenchymal architecture [179].”
BackgroundBarkestani, M. N., Naserian, S., Uzan, G., & Shamdani, S. (2021) · Journal of Tissue Engineering · doi:10.1177/2041731420983562 · Cited by 42
Decellularized liver transplant could be recellularized in rat partial hepatectomy model
Naeem, E. M., Sajad, D., Talaei‐Khozani, T., Khajeh, S., Azarpira, N., Alaei, S., Tanideh, N., Reza, T. M., & Razban, V. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36763 · Cited by 38
Decellularized Human Chorion Membrane as a Novel Biomaterial for Tissue Regeneration
Frazão, L. P., de Castro, J. V., Nogueira‐Silva, C., & Neves, N. M. (2020) · Biomolecules · doi:10.3390/biom10091208 · Cited by 38
Predeina, A. L., Dukhinova, M., & Vinogradov, V. V. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01751e · Cited by 41
Ahmed, E., Saleh, T., Yu, L., Kwak, H.-H., Kim, B.-M., Park, K.-M., Lee, Y.-S., Kang, B.-J., Choi, K.-Y., Kang, K.-S., et al. (2019) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2019.02.007 · Cited by 37
Sharma, A., Rawal, P., Tripathi, D. M., Alodiya, D., Sarin, S. K., Kaur, S., & Ghosh, S. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00671 · Cited by 35
Peptide-based scaffolds for the culture and maintenance of primary human hepatocytes
MacPherson, D., Bram, Y., Park, J., & Schwartz, R. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86016-5 · Cited by 36
Recent Advances in Decellularization and Recellularization for Tissue-Engineered Liver Grafts
Wang, Y., Nicolas, C. T., Chen, H. S., Ross, J. J., De Lorenzo, S. B., & Nyberg, S. L. (2017) · Cells Tissues Organs · doi:10.1159/000452761 · Cited by 36
Decellularized Human Gut as a Natural 3D Platform for Research in Intestinal Fibrosis
Giuffrida, P., Curti, M., Al-Akkad, W., Biel, C., Crowley, C., Frenguelli, L., Telese, A., Hall, A., Tamburrino, D., Spoletini, G., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz115 · Cited by 34
Self-citationEmerging liver organoid platforms and technologies
Lam, D. T. U. H., Dan, Y. Y., Chan, Y.-S., & Ng, H.-H. (2021) · Cell Regeneration · doi:10.1186/s13619-021-00089-1 · Cited by 32
Recent Advances in Decellularization and Recellularization for Tissue-Engineered Liver Grafts
Wang, Y., Nicolas, C. T., Chen, H. S., Ross, J. J., De Lorenzo, S. B., & Nyberg, S. L. (2017) · Cells Tissues Organs · doi:10.1159/000479597 · Cited by 32
de Jongh, D., Massey, E. K., Cronin, A. J., Schermer, M., & Bunnik, E. M. (2022) · Transplant International · doi:10.3389/ti.2022.10751 · Cited by 37
“Similarly, in other disease areas, first steps are being taken towards the generation of transplantable bioartificial organs, including livers (1), bladders (2), kidneys (3), hearts (4), small intestines (5) and lungs (6, 7).”
BackgroundPouraghaei, S., Ansari, S., & Moshaverinia, A. (2021) · International Journal of Oral Science · doi:10.1038/s41368-021-00126-4 · Cited by 37
Samat, A. A., Hamid, Z. A. A., Mariatti, M., Ong, C. C., & Yahaya, B. H. (2023) · Bioengineering · doi:10.3390/bioengineering10040394 · Cited by 36
Vasculature reconstruction of decellularized liver scaffolds via gelatin‐based re‐endothelialization
Meng, F., Almohanna, F., Altuhami, A., Assiri, A. M., & Broering, D. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36551 · Cited by 31
Rethinking Regenerative Medicine From a Transplant Perspective (and Vice Versa)
Orlando, G., Murphy, S. V., Bussolati, B., Clancy, M. J., Cravedi, P., Migliaccio, G., & Murray, P. A. (2018) · Transplantation · doi:10.1097/tp.0000000000002370 · Cited by 32
“Since the milestone report on the bioengineering of a functional heart in 2008[13], more than two hundreds papers have proven that aECMs may be produced from virtually all transplantable organs from clinically relevant animal [11, 14-16] and human donors [16-24], including the human hand, face and face subunits [25-29…”
BackgroundKey aspects for conception and construction of co-culture models of tumor-stroma interactions
Mason, J. E., & Öhlund, D. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1150764 · Cited by 32
Al‐Dhamin, Z., Liu, L., Li, D., Zhang, S., Dong, S., & Nan, Y. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i47.7444 · Cited by 35
Lorvellec, M., Scottoni, F., Crowley, C., Fiadeiro, R., Maghsoudlou, P., Pellegata, A. F., Mazzacuva, F., Gjinovci, A., Lyne, A.-M., Zulini, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189586 · Cited by 31
Self-citationHuman Hepatocyte Transplantation: Three Decades of Clinical Experience and Future Perspective
Nulty, J., Anand, H., & Dhawan, A. K. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad084 · Cited by 30
Scaffold-mediated liver regeneration: A comprehensive exploration of current advances
Supriya Bhatt, S., Kumar, J. K., Laya, S., Thakur, G., & Nune, M. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241286092 · Cited by 30
“29 Pore architecture and porosity are critical determinants influencing cellular behavior and overall scaffold functionality.”
BackgroundInfluence of surface topography on PCL electrospun scaffolds for liver tissue engineering
Gao, Y., & Callanan, A. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00789k · Cited by 29
Ogunlade, O. O., Ho, J. O. Y., Kalber, T. L., Hynds, R. E., Zhang, E., Janes, S. M., Birchall, M., Butler, C. R., & Beard, P. C. (2019) · Photoacoustics · doi:10.1016/j.pacs.2019.01.001 · Cited by 29
“This is broadly consistent with the timescale observed in previous studies for the emergence of neovessels in tissue-engineered scaffolds implanted subcutaneously in rodents [31,32].”
ResultHussein, K. H., Ahmadzada, B., Correa, J. C., Sultan, A., Wilken, S., Amiot, B., & Nyberg, S. L. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.06.001 · Cited by 28
“HepG2 cells efficiently repopulate decel-lularized rat, porcine, and human livers while retaining their function and proliferative capacity [14,15,204].”
BackgroundMethodInfluentialWu, G., Wu, D., Lo, J., Wang, Y., Wu, J., Lu, S., Xu, H., Zhao, X., He, Y., Li, J., et al. (2020) · Biomaterials Science · doi:10.1039/c9bm01879d · Cited by 28
Gao, Y., Bate, T. S. R., & Callanan, A. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00032 · Cited by 28
Decellularized Tissue Matrix for Stem Cell and Tissue Engineering
Lee, J. S., Choi, Y. S., & Cho, S. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0445-3_10 · Cited by 30
Abazari, M. F., Soleimanifar, F., Enderami, S. E., Nasiri, N., Nejati, F., Mousavi, S. A., Soleimani, M., Kiani, J., Ghoraeian, P., & Kehtari, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29351 · Cited by 29
“Previous studies had shown that ECM components of dAM such as collagens type III, IV; fibronectin and laminin, which have a similar biological properties with hepatic matrix, make dAM attractive material to fabricate scaffold for liver tissue engineering.(53,54) In the present study, we have also confirmed that amniot…”
BackgroundTissue engineering of the biliary tract and modelling of cholestatic disorders
Brevini, T., Tysoe, O., & Sampaziotis, F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.049 · Cited by 29
Thanapirom, K., Caon, E., Papatheodoridi, Μ., Frenguelli, L., Al‐Akkad, W., Zhenzhen, Z., Vilia, M. G., Pinzani, M., Mazza, G., & Rombouts, K. (2021) · Cancers · doi:10.3390/cancers13194936 · Cited by 32
“Healthy liver was defined if there was no evidence of fibrosis and fat accu‐ mulation [12,21].”
BackgroundMethodInfluentialSelf-citationKlaas, M., Möll, K., Mäemets‐Allas, K., Loog, M., Järvekülg, M., & Jaks, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-99659-1 · Cited by 28
Cell transplantation-based regenerative medicine in liver diseases
Cardinale, V., Lanthier, N., Baptista, P. M., Carpino, G., Carnevale, G., Orlando, G., Angelico, R., Manzia, T. M., Schuppan, D., Pinzani, M., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.06.005 · Cited by 33
“By 2010, this technology was successfully adopted for whole livers of rats, mice, ferrets, rabbits, and pigs (Baptista et al., 2011; Mazza et al., 2015; Uygun et al., 2010; Yagi et al., 2013) opening the door to human-size liver bioengineering.”
Self-citationNatural Killer Cells in Liver Disease
Stegmann, K. A., Easom, N. J. W., Maini, M. K., & Male, V. H. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1603946 · Cited by 32
Willemse, J., van der Laan, L. J. W., de Jonge, J., & Verstegen, M. M. A. (2022) · Bioengineering · doi:10.3390/bioengineering9030110 · Cited by 28
Development and Characterization of a Porcine Liver Scaffold
Ansari, T., Southgate, A., Obiri-Yeboa, I., Jones, L. G., Greco, K., Olayanju, A., Mbundi, L., Somasundaram, M., Davidson, B., & Sibbons, P. D. (2020) · Stem Cells and Development · doi:10.1089/scd.2019.0069 · Cited by 26
“To date, different approaches have been developed for creating acellular liver matrices from different species, for example, rodents [10,11], porcine [12–14], sheep [15], and human [16,17] using various combinations of chemicals, enzymes, and physical forces.”
Self-citationEmerging trends in modeling human liver disease in vitro
Underhill, G. H., & Khetani, S. R. (2019) · APL Bioengineering · doi:10.1063/1.5119090 · Cited by 30
Engineering Cell‐Derived Matrices: From 3D Models to Advanced Personalized Therapies
Rubí-Sans, G., Castaño, Ó., Cano, I., Mateos‐Timoneda, M. A., Pérez‐Amodio, S., & Engel, E. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000496 · Cited by 26
Leslie, J., Krishnamurthy, K. A., Gopalsamy, I. K., Inácio, P., Huch, M., Gallage, S., Oakley, F., & Vacca, M. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01162-9 · Cited by 30
Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases
Cernigliaro, V., Peluso, R., Zedda, B., Silengo, L., Tolosano, E., Pellicano, R., Altruda, F., & Fagoonee, S. (2020) · Cells · doi:10.3390/cells9020386 · Cited by 26
“The first successful decellularization of a human liver and repopulation with derived human liver cells was performed in 2015 by using a novel retrograde, two-step, perfusion flow-rate methodology able to preserve the 3D hepatic architecture and composition, and guarantee excellent viability, motility and cell prolife…”
MethodHyung, S., Jeong, J., Shin, K., Kim, J. Y., Yim, J., Yu, C. J., Jung, H. S., Hwang, K., Choi, D., & Hong, J. W. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27447 · Cited by 26
“…2019; Michalopoulos & Khan, 2005), and extra-cellular matrix ‐ based technology (e.g., decellularization, De Kock et al., 2011; Klaas et al., 2016; Mazza et al., 2015; Pla ‐ Palacin, Sainz ‐ Arnal, Morini, Almeida, & Baptista, 2018) are remarkable regeneration resources; however, little is known…”
The Applications and Challenges of the Development of In Vitro Tumor Microenvironment Chips
Johnson, A., Reimer, S., Childres, R., Cupp, G., Kohs, T. C. L., McCarty, O. J. T., & Kang, Y. B. (2022) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-022-00755-7 · Cited by 26
A New Chapter for Mesenchymal Stem Cells: Decellularized Extracellular Matrices
Anasiz, Y., Özgül, R. K., & Uçkan, D. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9757-x · Cited by 28
Advances in the generation of bioengineered bile ducts
Justin, A. W., Saeb‐Parsy, K., Markaki, A. E., Vallier, L., & Sampaziotis, F. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.034 · Cited by 25
Technological advancements for the development of stem cell-based models for hepatotoxicity testing
Natale, A., Vanmol, K., Arslan, A., Vlierberghe, S. V., Dubruel, P., Erps, J. V., Thienpont, H., Buzgo, M., Boeckmans, J., Kock, J. D., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02465-y · Cited by 27
Calitz, C., Pavlović, N., Rosenquist, J., Zagami, C., Samanta, A., & Heindryckx, F. (2020) · Journal of Visualized Experiments · doi:10.3791/61606 · Cited by 27
Howaili, F., Mashreghi, M., SHahri, N. M., Kompany, A., & Jalal, R. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109823 · Cited by 24
Decellularization of various tissues and organs through chemical methods
Tabatabai, T. S., Salehi, M., Rezakhani, L., Arabpour, Z., Djalilian, A. R., & Alizadeh, M. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102573 · Cited by 27
Rhenium Perrhenate (188ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells
Asadian, S., Piryaei, A., Gheibi, N., Kalantari, B. A., Davarpanah, M. R., Azad, M., Kapustina, V., Alikhani, M., Nejad, S. M., Alikhani, H. K., et al. (2022) · Cells · doi:10.3390/cells11020305 · Cited by 24
“Therefore, HCC cells cultured in decellularized 3D scaffolds can provide a better platform for drug toxicity assessments than conventional 2D culture systems [53,54].”
BackgroundLiver Bioengineering: Promise, Pitfalls, and Hurdles to Overcome
Acun, A., Oganesyan, R. V., & Uygun, B. E. (2019) · Current Transplantation Reports · doi:10.1007/s40472-019-00236-3 · Cited by 23
Machine Perfusion of the Liver: Applications Beyond Transplantation
Hefler, J., Marfil‐Garza, B. A., Dadheech, N., & Shapiro, A. M. J. (2020) · Transplantation · doi:10.1097/tp.0000000000003320 · Cited by 24
“Some groups have even made use of decellularized human livers from discarded grafts.(59) Ex situ may offer a solution to this problem, though it comes with its own challenges of organ availability and procurement.”
BackgroundXu, J., Fang, Q., Liu, Y., Zhou, Y., Ye, Z., & Tan, W. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111374 · Cited by 23
Whole liver engineering: A promising approach to develop functional liver surrogates
Meng, F., Assiri, A. M., Dhar, D. K., & Broering, D. (2017) · Liver International · doi:10.1111/liv.13444 · Cited by 23
Self-citationAdvancements in MAFLD Modeling with Human Cell and Organoid Models
Wang, S.-X., Yan, J.-S., & Chan, Y.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911850 · Cited by 22
“An alternative approach to harness human and mammalian liver organs and tissue to generate an organ-like culture in vitro is the use of decellularized organ scaffolds [165,178,179].”
BackgroundRegenerative medicine technologies applied to transplant medicine. An update
Petrosyan, A., Montali, F., Peloso, A., Citro, A., Byers, L. N., Pointe, C. L., Suleiman, M., Marchetti, A., McNeill, E. P., Speer, A. L., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1015628 · Cited by 25
In-vivo organ engineering: Perfusion of hepatocytes in a single liver lobe scaffold of living rats
Pan, J., Yan, S., Gao, J., Wang, Y., Lu, Z., Cui, C.-W., Zhang, Y., Wang, Y., Meng, X., Zhou, L., et al. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.10.003 · Cited by 23
Asadi, M., Khalili, M., Lotfi, H., Moghaddam, S. V., Zarghami, N., André, H., & Alizadeh, E. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119373 · Cited by 22
Roudaut, M., Caillaud, A., Souguir, Z., Bray, L., Girardeau, A., Rimbert, A., Croyal, M., Lambert, G. C., Patitucci, M., Delpouve, G., et al. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10659 · Cited by 24
Zhang, Z., Xu, H., Mazza, G., Zhang, M., Frenguelli, L., Liu, Q., Al‐Akkad, W., Ren, J., Zhao, R., Ren, F., et al. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36690 · Cited by 23
Self-citationRecent advances in the development of in vitro liver models for hepatotoxicity testing
Lu, S., Zhang, J., Lin, S., Zheng, D., Shen, Y., Qin, J., Li, Y. Y., & Wang, S. (2021) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00142-7 · Cited by 25
In vitro and in vivo translational models for rare liver diseases
Haugabook, S. J., Ferrer, M., & Ottinger, E. A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.029 · Cited by 24
Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema
Sung, C., Gupta, K., Wang, J., & Wong, A. K. (2022) · Bioengineering · doi:10.3390/bioengineering9040162 · Cited by 21
Kasravi, M., Yaghoobi, A., Tayebi, T., Hojabri, M., Taheri, A. T., Shirzad, F., Nooshin, B. J., Mazloomnejad, R., Ahmadi, A., Tehrani, F. A., et al. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213710 · Cited by 22
Chang, S. H., Huang, H. H., Kang, P. L., Wu, Y. C., Chang, M.-H., & Kuo, S. M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.09.028 · Cited by 20
Role of Biological Scaffolds, Hydro Gels and Stem Cells in Tissue Regeneration Therapy
Upadhyay, R. K. (2017) · Advances in Tissue Engineering & Regenerative Medicine Open Access · doi:10.15406/atroa.2017.02.00020 · Cited by 26
“This technology used to engineer lungs [66], tissue grafts for heart [67], liver [68] and pancreas in vitro [69].”
MethodAmyloid persistence in decellularized liver: biochemical and histopathological characterization
Mazza, G., Simons, J. P., Al‐Shawi, R., Ellmerich, S., Urbani, L., Giorgetti, S., Taylor, G. W., Gilbertson, J. A., Hall, A. R., Al‐Akkad, W., et al. (2015) · Amyloid · doi:10.3109/13506129.2015.1110518 · Cited by 20
Self-citationBiomimicked hierarchical 2D and 3D structures from natural templates: applications in cell biology
Yadav, S., & Majumder, A. (2021) · Biomedical Materials · doi:10.1088/1748-605x/ac21a7 · Cited by 19
“In 2015, Mazza et al reported method of decel-lularization of human liver (Mazza et al 2015).”
Impact of Percoll purification on isolation of primary human hepatocytes
Horner, R., Gassner, J. G. M. V., Kluge, M., Tang, P., Lippert, S., Hillebrandt, K. H., Moosburner, S., Reutzel‐Selke, A., Pratschke, J., Sauer, I. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43042-8 · Cited by 22
Modelling Pancreatic Neuroendocrine Cancer: From Bench Side to Clinic
Ney, A., Canciani, G., Hsuan, J. J., & Pereira, S. P. (2020) · Cancers · doi:10.3390/cancers12113170 · Cited by 20
Saleh, T., Ahmed, E., Yu, L., Song, S., Park, K., Kwak, H., & Woo, H. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36920 · Cited by 21
Human Liver-Derived Extracellular Matrix for the Culture of Distinct Human Primary Liver Cells
Alevra Sarika, N., Payen, V. L., Fléron, M., Ravau, J., Brusa, D., Najimi, M., De Pauw, E., Eppe, G., Mazzucchelli, G., Sokal, E. M., et al. (2020) · Cells · doi:10.3390/cells9061357 · Cited by 18
“Cryopreserved healthy liver fragments (non-inflamed, non-fibrotic) from four donors were decellularized as previously described [13,17,23] with some modifications (Figure S1A).”
MethodTooth-derived stem cells integrated biomaterials for bone and dental tissue engineering
Vimalraj, S., & Sekaran, S. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03815-0 · Cited by 20
“…been shown that decellularised tooth buds may serve as a sufficient platform for the differentiation of dental MSCs, allowing for the development of a complete tooth with well-organised dentin and enamel-like structures (Mazza et al. 2015; Wang et al. 2016; Santi et al. 2016; Zhang et al. 2017).”
BackgroundChallenges on the road to a multicellular bioartificial liver
Starokozhko, V., & Groothuis, G. M. M. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2385 · Cited by 19
“Recently, it was shown for the first time that decellularization of human livers that are not suitable for transplantation is possible (Mazza et al., 2015).”
BackgroundAccounting for Material Changes in Decellularized Tissue with Underutilized Methodologies
Hansen, R. A. B., Wang, X., Kaw, G., Pierre, V., & Senyo, S. E. (2021) · BioMed Research International · doi:10.1155/2021/6696295 · Cited by 20
“SEM Fiber organization/scaffold structure Native and decellularized human liver cubes [4, 109]; native and decellularized zebrafish andmouse heart matrix [7]; native and decellularized pig myocardium layers [77]; native and decellularized rat kidney [80, 110];”
BackgroundMußbach, F., Settmacher, U., Dirsch, O., Xie, C., & Dahmen, U. (2016) · European Surgical Research · doi:10.1159/000446211 · Cited by 19
Metadata
- Authors
- Mazza, G., Rombouts, K., Rennie Hall, A., Urbani, L., Vinh Luong, T., Al-Akkad, W., Longato, L., Brown, D., Maghsoudlou, P., Dhillon, A. P., Fuller, B., Davidson, B., Moore, K., Dhar, D., De Coppi, P., Malago, M., & Pinzani, M.
- Affiliations
- University College London (GB)
- Great Ormond Street Hospital (GB)
- The Royal Free Hospital (GB)
- Royal Free London NHS Foundation Trust (GB)
- Corresponding author
- Mazza, Giuseppe
- ORCID
- Venue
- Scientific Reports
- Published
- 2015-08-07
- Volume
- 5
- Issue
- 1
- Pages
- 13079-13079
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4528226
- OpenAlex
- W1061628335
- Cited by
- 415
- References
- 34
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 23 · 2023: 34 · 2022: 37 · 2021: 45 · 2020: 54 · 2019: 54 · 2018: 42 · 2017: 53 · 2016: 25 · 2015: 3
- FWCI
- 41.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Explore Bristol Research (submittedVersion)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research
- Great Ormond Street Hospital Charity
- Medical Research Council
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Keywords
- extracellular matrix scaffolds, 3D scaffolds, liver transplantation, bioartificial liver, hepatic stellate cells, hepatocellular carcinoma cells, hepatoblastoma cells, xenotransplantation, biocompatibility, foreign body reaction, extracellular matrix remodeling
- MeSH terms
- Animals, Biomedical Engineering, Extracellular Matrix, Carcinoma, Hepatocellular, Humans, Liver, Male, Mice, Inbred C57BL, Transplantation, Heterologous, Liver Transplantation, Hepatoblastoma, Hepatocytes, Tissue Engineering, Cell Line, Tumor, Mice, Tissue Scaffolds, Hepatic Stellate Cells, Hep G2 Cells, Bioengineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.